Moreover, it has been reported that downregulation of miR-21 expression results in decreased hepatic steatosis through upregulation of activities of PTEN [18], HBP1-p53 [19] and PPARα [20] pathways. The gene discussed is PPARA; the disease is fatty liver disease.